200 related articles for article (PubMed ID: 8789309)
1. Prothrombin fragment 1 + 2 and thrombin-antithrombin III complex as markers of activation of blood coagulation in inflammatory bowel diseases.
Chamouard P; Grunebaum L; Wiesel ML; Frey PL; Wittersheim C; Sapin R; Baumann R; Cazenave JP
Eur J Gastroenterol Hepatol; 1995 Dec; 7(12):1183-8. PubMed ID: 8789309
[TBL] [Abstract][Full Text] [Related]
2. Coagulation and fibrinolysis in children, adolescents, and young adults with inflammatory bowel disease.
Weber P; Husemann S; Vielhaber H; Zimmer KP; Nowak-Göttl U
J Pediatr Gastroenterol Nutr; 1999 Apr; 28(4):418-22. PubMed ID: 10204507
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the prethrombotic state in pregnancy and in women using oral contraceptives.
Levine AB; Teppa J; McGough B; Cowchock FS
Contraception; 1996 May; 53(5):255-7. PubMed ID: 8724613
[TBL] [Abstract][Full Text] [Related]
4. Age-based difference in activation markers of coagulation and fibrinolysis in extracorporeal membrane oxygenation.
Hundalani SG; Nguyen KT; Soundar E; Kostousov V; Bomgaars L; Moise A; Hui SK; Teruya J
Pediatr Crit Care Med; 2014 Jun; 15(5):e198-205. PubMed ID: 24614609
[TBL] [Abstract][Full Text] [Related]
5. Prothrombin fragment 1 + 2 and antithrombin III-thrombin complex in microalbuminuric type 2 diabetic patients.
Gruden G; Cavallo-Perin P; Romagnoli R; Olivetti C; Frezet D; Pagano G
Diabet Med; 1994 Jun; 11(5):485-8. PubMed ID: 8088128
[TBL] [Abstract][Full Text] [Related]
6. Thrombin generation and activation of the thrombomodulin protein C system in open heart surgery depend on the underlying cardiac disease.
Welters I; Menges T; Ballesteros M; Knothe C; Ruwoldt R; Görlach G; Hempelmann G
Thromb Res; 1998 Oct; 92(1):1-9. PubMed ID: 9783668
[TBL] [Abstract][Full Text] [Related]
7. Association between enhanced soluble CD40 ligand and prothrombotic state in inflammatory bowel disease.
Koutroubakis IE; Theodoropoulou A; Xidakis C; Sfiridaki A; Notas G; Kolios G; Kouroumalis EA
Eur J Gastroenterol Hepatol; 2004 Nov; 16(11):1147-52. PubMed ID: 15489574
[TBL] [Abstract][Full Text] [Related]
8. Prothrombin activation fragment 1 + 2 and thrombin-antithrombin-III complexes in plasma of patients with essential arterial hypertension.
Kłoczko J; Wojtukiewicz MZ; Galar M; Tarasów E; Jaromin J; Bielawiec M
Pol J Pharmacol; 1996; 48(2):233-5. PubMed ID: 9112658
[TBL] [Abstract][Full Text] [Related]
9. Markers of coagulation and fibrinolysis as measures of disease activity in inflammatory bowel disease.
Kjeldsen J; Lassen JF; Brandslund I; Schaffalitzky de Muckadell OB
Scand J Gastroenterol; 1998 Jun; 33(6):637-43. PubMed ID: 9669637
[TBL] [Abstract][Full Text] [Related]
10. Significance of diminished factor XIII in Crohn's disease.
Chamouard P; Grunebaum L; Wiesel ML; Sibilia J; Coumaros G; Wittersheim C; Baumann R; Cazenave JP
Am J Gastroenterol; 1998 Apr; 93(4):610-4. PubMed ID: 9576457
[TBL] [Abstract][Full Text] [Related]
11. Activation of the extrinsic coagulation pathway in patients with severe sepsis and septic shock.
Gando S; Nanzaki S; Sasaki S; Aoi K; Kemmotsu O
Crit Care Med; 1998 Dec; 26(12):2005-9. PubMed ID: 9875912
[TBL] [Abstract][Full Text] [Related]
12. Prothrombin fragment F1 + 2 and thrombin-antithrombin III complex are useful markers of the hypercoagulable state in atrial fibrillation.
Asakura H; Hifumi S; Jokaji H; Saito M; Kumabashiri I; Uotani C; Morishita E; Yamazaki M; Shibata K; Mizuhashi K
Blood Coagul Fibrinolysis; 1992 Aug; 3(4):469-73. PubMed ID: 1420823
[TBL] [Abstract][Full Text] [Related]
13. Are prothrombin fragment 1 + 2 and thrombin-antithrombin complexes useful in the management of oral anticoagulant therapy?
Barcellona D; Biondi G; Mameli G; Marongiu F
Int J Clin Lab Res; 1997; 27(1):76-8. PubMed ID: 9144033
[TBL] [Abstract][Full Text] [Related]
14. Modified antithrombin III levels during normal pregnancy and relationship with prothrombin fragment F1 + 2 and thrombin-antithrombin complexes.
Reber G; Amiral J; de Moerloose P
Thromb Res; 1998 Jul; 91(1):45-7. PubMed ID: 9700853
[No Abstract] [Full Text] [Related]
15. Measurement of markers of activated coagulation in antithrombin III deficient subjects.
Demers C; Ginsberg JS; Henderson P; Ofosu FA; Weitz JI; Blajchman MA
Thromb Haemost; 1992 May; 67(5):542-4. PubMed ID: 1519214
[TBL] [Abstract][Full Text] [Related]
16. Enhanced thrombin generation in children with sickle cell disease.
Peters M; Plaat BE; ten Cate H; Wolters HJ; Weening RS; Brandjes DP
Thromb Haemost; 1994 Feb; 71(2):169-72. PubMed ID: 8191393
[TBL] [Abstract][Full Text] [Related]
17. Persistent activation of coagulation and fibrinolysis after treatment of active ulcerative colitis.
van Bodegraven AA; Schoorl M; Linskens RK; Bartels PC; Tuynman HA
Eur J Gastroenterol Hepatol; 2002 Apr; 14(4):413-8. PubMed ID: 11943956
[TBL] [Abstract][Full Text] [Related]
18. Influence of conditions of blood sampling on coagulation activation markers (prothrombin fragment 1 + 2, thrombin-antithrombin complexes and D-dimers) measurements.
Leroy-Matheron C; Gouault-Heilmann M
Thromb Res; 1994 May; 74(4):399-407. PubMed ID: 8085241
[TBL] [Abstract][Full Text] [Related]
19. No evidence of activated blood coagulation in Crohn's disease.
Novacek G; Kapiotis S; Moser G; Speiser W; Gangl A; Vogelsang H
Eur J Gastroenterol Hepatol; 1997 Oct; 9(10):963-7. PubMed ID: 9391785
[TBL] [Abstract][Full Text] [Related]
20. Determination of markers of coagulation activation and reactive fibrinolysis in patients with mechanical heart valve prosthesis at different intensities of oral anticoagulation.
van Wersch JW; van Mourik-Alderliesten CH; Coremans A
Blood Coagul Fibrinolysis; 1992 Apr; 3(2):183-6. PubMed ID: 1606289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
